Yet, given clear inherent differences between murine and human iNKT cells, as well as the correlative human studies suggesting that donor graft CD4- iNKT cells are most protective against GVHD, one might weigh the xenograft results heavier. This evidence concerns the gene CD4 and graft versus host disease.